Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-04-14 Sale | 2021-04-14 4:19 pm | HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director | 5,000 | $45 | $225,000 | 179,833 (Direct) | View |
2021-03-01 Sale | 2021-03-01 8:08 pm | HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director | 5,000 | $45.34 | $226,717 | 184,833 (Direct) | View |
2021-02-01 Sale | 2021-02-01 6:56 pm | HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director | 5,000 | $48.12 | $240,594 | 189,833 (Direct) | View |
2021-01-04 Sale | 2021-01-04 5:07 pm | HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director | 5,000 | $42.91 | $214,556 | 194,833 (Direct) | View |
2020-12-07 Sale | 2020-12-07 6:05 pm | HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director | 35,086 | $41 | $1,438,526 | 199,833 (Direct) | View |
2020-12-02 Sale | 2020-12-02 5:55 pm | HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director | 31,792 | $41 | $1,303,472 | 234,919 (Direct) | View |
2020-11-25 Sale | 2020-11-27 5:43 pm | HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director | 19,671 | $41.37 | $813,850 | 266,711 (Direct) | View |
2020-03-19 Purchase | 2020-03-19 7:28 pm | HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director | 52,629 | $14.23 | $748,697 | 277,553 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-04-30 Option Award | 2020-05-01 7:12 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director | 8,829 | $0 | 286,382 (Direct) | View |